Mereo BioPharma Group plc - SPON ADS (MREO)

Historical Portfolio Holders from Q2 2019 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / SPON ADS
Shares, excl. options Q2 2024
101M
Holdings value Q2 2024
$362M
Value change Q2 2024
+$59.8M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
76
Number of buys Q2 2024
33
Number of sells Q2 2024
-42
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 101M $362M +$59.8M $3.60 76
2024 Q1 84M $277M +$19.5M $3.30 78
2023 Q4 78.5M $181M +$20.4M $2.31 61
2023 Q3 69.9M $90.2M +$9.9M $1.29 53
2023 Q2 63.6M $84M +$2.49M $1.32 50
2023 Q1 60.8M $43M -$705K $0.71 56
2022 Q4 61.6M $46.1M -$7.66M $0.75 58
2022 Q3 68M $58.5M -$7.13M $0.86 56
2022 Q2 73.6M $82.5M -$16.9M $1.12 58
2022 Q1 88.9M $99.6M -$3.07M $1.12 55
2021 Q4 90.9M $145M -$12.3M $1.60 68
2021 Q3 87.5M $212M -$26.6M $2.42 57
2021 Q2 89.6M $284M -$2.19M $3.17 67
2021 Q1 90.2M $304M +$111M $3.37 64
2020 Q4 57.1M $205M +$140M $3.58 44
2020 Q3 14.3M $37.4M +$18M $2.62 20
2020 Q2 7.28M $22.3M +$12.6M $3.06 20
2020 Q1 3.28M $3.42M +$2.09M $1.05 7
2019 Q4 1.24M $4.06M -$2.41M $3.28 9
2019 Q3 1.78M $5.21M -$43.4K $2.97 13
2019 Q2 1.72M $4.19M +$4.19M $2.43 14